AMA Wants to Halt DTC Drug Ads

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

NEW YORK The American Medical Association is calling for a temporary moratorium on direct-to-consumer prescription drug and implantable medical device advertising.

Nearly 10 years after the U.S. government began allowing companies to pitch their products on television, leading to a boom in costly advertising campaigns for branded drugs, the Chicago-based doctors group wants to rethink the policy.

“A temporary moratorium on DTC advertising of prescribed drugs and medical devices will benefit both the patient and physician,” said AMA president-elect Dr.



AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in